comparemela.com

Latest Breaking News On - Institutional investors weigh in on amneal pharmaceuticals - Page 1 : comparemela.com

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s stock price shot up 6.4% on Tuesday . The company traded as high as $6.90 and last traded at $6.86. 685,390 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 1,502,379 shares. The stock had previously closed at $6.45. Analysts […]

Piper-sandler
Sherbrooke-park-advisers
Barclays
News-ratings-for-amneal-pharmaceuticals-daily
Amneal-pharmaceuticals
Atlanta-consulting-group-advisors
Nasdaq
Amneal-pharmaceuticals-company-profile
Amneal-pharmaceuticals-inc
Amneal-pharmaceuticals-stock-performance
Goldman-sachs-group
Institutional-investors-weigh-in-on-amneal-pharmaceuticals

Amneal Pharmaceuticals' (AMRX) "Buy" Rating Reiterated at Truist Financial

Amneal Pharmaceuticals' (AMRX) "Buy" Rating Reiterated at Truist Financial
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Goldman-sachs-group
Institutional-investors-weigh-in-on-amneal-pharmaceuticals
Amneal-pharmaceuticals
Amneal-pharmaceuticals-stock-performance
News-ratings-for-amneal-pharmaceuticals-daily
Raymond-james-associates
York-mellon-corp
Barclays
Principal-financial-group-inc
Nasdaq
Sg-americas-securities

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been given an average recommendation of “Buy” by the four research firms that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have covered the […]

Ohio
United-states
Piper-sandler
Amneal-pharmaceuticals-inc
Barclays
Goldman-sachs-group
Institutional-investors-weigh-in-on-amneal-pharmaceuticals
Amneal-pharmaceuticals
Connor-clark-lunn-investment-management-ltd
Nasdaq
News-ratings-for-amneal-pharmaceuticals-daily
Amneal-pharmaceuticals-stock-performance

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […]

Piper-sandler
Barclays
Voloridge-investment-management
News-ratings-for-amneal-pharmaceuticals-daily
Barclays-plc
Group-plc
Institutional-investors-weigh-in-on-amneal-pharmaceuticals
Goldman-sachs-group
Amneal-pharmaceuticals
Amneal-pharmaceuticals-inc
Nasdaq
Amneal-pharmaceuticals-company-profile

Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volume

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 454,208 shares traded hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Wall Street Analyst Weigh In Several research analysts recently […]

Hong-kong
United-states
American
Piper-sandler
American-century-companies-inc
Y-intercept-hong-kong-ltd
Amneal-pharmaceuticals-price-performance
Barclays
Tower-research-capital
Nasdaq
Amneal-pharmaceuticals-inc
News-ratings-for-amneal-pharmaceuticals-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.